Date post: | 08-Apr-2018 |
Category: |
Documents |
Upload: | duongthuan |
View: | 215 times |
Download: | 3 times |
Natus Medical Incorporated
Jeffries Global Healthcare
CONFERENCE
Tuesday June 6, 2017
2
Forward-Looking StatementsThis presentation contains forward-looking statements including statements regarding ourexpectations, beliefs, plans and intentions, which involve known and unknown risks,uncertainties, and other factors which may cause our actual results, performance, orachievements to be materially different from any future results, performance, orachievements expressed or implied by any forward looking statements. These statementsreflect our current views with respect to future events and are based on assumptions, andsubject to risks and uncertainties. Given these uncertainties, you should not place unduereliance on these forward-looking statements. We discuss many of these risks in greaterdetail in our filings with the SEC, which you should read carefully. You should listen to theinformation contained in this presentation completely with the understanding that ouractual future results may be materially different from what we expect, and from historicalresults and trends. We qualify all our forward-looking statements by these cautionarystatements. Natus disclaims any obligation to update information contained in any forward-looking statement.
Reconciliation of GAAP to non-GAAP results are contained in our press releases and SECfilings.
Natus is a leading provider of medical devices for the newborn care, hearing and neurologymarkets. Additional information about Natus Medical can be found at www.natus.com.
3
About Natus
Neurodiagnostics
Newborn Care
Otometrics
48%
31%
21%
EEGElectroencephalography
EMGElectromyography
Hearing Screening
Brain Injury
Phototherapy
Hearing Screening
Hearing Aid Fitting
Balance
Hearing Diagnostics
4
Revenue Growth: 10-YR CAGR ~ 19%Organic growth and acquisitions$ millions
$90
$292
$382
2006 2012 2016 2017 Guidance
Guidance
$505 –$510
5
Non-GAAP Operating Margin Growth
*Non-GAAP earnings excl. intangible amort., restructurings, and certain other one-time items. For more information, please see our periodic press releases and associated SEC filings at http://investor.natus.com.
9%
14%
16%
19%18%
15%
20%
2012 2013 2014 2015 2016 2017 Guidance GOAL
Otometrics Acquisition
6
$ millions
0.63
1.04
1.26
1.551.62
2012 2013 2014 2015 2016 2017 Guidance
Non-GAAP EPS Growth
Guidance
$1.70 –$1.75
*FY’17 guidance as of April 26, 2017. Non-GAAP earnings excl. intangible amort., restructurings, and certain other one-time items. For more information, please see our periodic press releases and associated SEC filings at http://investor.natus.com.
PhototherapyHearing Screening Brain Injury
NEWBORN CARE
8
Market Leader in Newborn CarePioneered newborn hearing screening
Worldwide Market Share
~70%
Hearing screening devices / disposables
Phototherapy
Services - Peloton
9
Peloton: Hearing Screening Service for Hospitals
• Opportunity to convert Natus Algo customers
• Hospital benefits
− Gain cost savings
− Eliminate screening management
Q1’14 Q4’16
0
127Hospitals
EEGElectroencephalography
EMGElectromyography
NEURODIAGNOSTICS
11
Market Leader in NeurodiagnosticsCompleted roll-up of fragmented market in 2012
Worldwide Market Share
~60%
EEG
EMG
Services - GND
*Worldwide market shares excludes Japanese market
12
Global Neurodiagnostics (GND)
• Provides in-home neurodiagnostic service
• Reduces overall payor cost by 50-65%
• Expanding in major U.S. markets
Entered market3 states
Growth into22 states
Q12015
Q42016
Growth into33 states
2017Goal
Hearing Diagnostics BalanceHearing ScreeningHearing Aid Fitting
OTOMETRICS
14
+A GLOBAL LEADER MARKET PRESENCE
• Newborn Hearing Screening
• Hearing diagnostics
• Balance assessment
• Hearing Aid Fitting
• Largest independent hearing aid fitting supplier
• Premium global brands
• Expanding margins as we complete integrations
15
Market Leader in AudiologyAcquired Otometrics January 2017
Hearing Screening
12%
Hearing Diagnostics
24%
Hearing Aid Fitting
40%
Balance11%
Supplies & Other
13%
% Revenue 2016 Hearing Screening
Hearing Aid Fitting
Balance Assessment
Hearing Diagnostics
16
% Revenue
-1%
10%
20%
Pre Acquisition 2017 2018
Otometrics Operating Margin Goals
17
% Annual Revenue
22%24% 24%
30%
Q1 Q2 Q3 Q4
Otometrics Revenue Cyclicality
18
2017 Guidance
Q2 2017 FY 2017
Consolidated Revenue $121M - $123M $505M - $510M
Non-GAAP EPS $0.32 - $0.34 $1.70 - $1.75
19
Natus Summary
• Leverage global marketing and distribution platform
• Targeted acquisitions with fiscal discipline
• Continued margin expansion and earnings growth
M A R K E T L E A D E R
Newborn Care AudiologyNeurodiagnostics
20